Literature DB >> 6978890

Plasma concentrations of vitamin D metabolites in puberty: effect of sexual maturation and implications for growth.

L Aksnes, D Aarskog.   

Abstract

To relate the vitamin D metabolism in puberty to sex, sexual maturation, and, indirectly, to growth velocity and cessation of growth, the plasma level of 25-hydroxy vitamin D, 1,25-dihydroxyvitamin D [1,25-(OH)2D], 24,25-dihydroxyvitamin D [24,25-(OH)2D], and 25,26-(OH)2D were measured in 191 adolescents representing all stages of puberty. In girls, 1,25-(OH)2D3 increased from age 11 yr to a peak at 12 yr of age (P less than 0.0005) and then decreased. In boys, the increase occurred between 13--14 yr of age (P less than 0.005), with a subsequent decline. When the 1,25-(OH)2D concentrations were related to the stage of puberty, the girls showed a maximal increase between stages 1 and 2 (P less than 0.0005), with a peak at stage 3, whereas the boys had a significant increase from stage 2 to a peak at stage 3 (P less than 0.01). In both sexes, there were subsequent significantly decreasing values to stage 4 through stage 5. The ratio of 24,25-(OH)2D to 25-hydroxyvitamin D varied inversely with the 1,25-(OH)2D concentration, with the lowest value at age 12 yr in both sexes, followed by a gradual increase to a plateau at age 15 yr in girls and 17 yr in boys. It appears that the hormones of the vitamin D system add another dimension to the endocrinology of growth and puberty.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978890     DOI: 10.1210/jcem-55-1-94

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  Adolescence: the period of dramatic bone growth.

Authors:  Connie M Weaver
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  Serum vitamin D metabolites are not related to growth rate, bone mineral content, or serum alkaline phosphatase in male puberty.

Authors:  S Krabbe; C Christiansen; L Hummer
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

3.  The effect of endogenous estrogen fluctuation on metabolism of 25-hydroxyvitamin D.

Authors:  J R Buchanan; R Santen; S Cauffman; A Cavaliere; R B Greer; L M Demers
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

Review 4.  Vitamin D: Musculoskeletal health.

Authors:  Harjit Pal Bhattoa; Jerzy Konstantynowicz; Natalia Laszcz; Marek Wojcik; Pawel Pludowski
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

Review 5.  Which vitamin D oral supplement is best for postmenopausal women?

Authors:  Heike A Bischoff-Ferrari
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

6.  Who gets renal bone disease before beginning dialysis?

Authors:  T Cundy; D J Hand; D O Oliver; C G Woods; F W Wright; J A Kanis
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26

7.  Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty.

Authors:  G Saggese; S Bertelloni; G I Baroncelli; R Battini; G Franchi
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

8.  Adequate vitamin D status and adiposity contribute to bone health in peripubertal nonobese children.

Authors:  Young Ah Lee; Ji Young Kim; Min Jae Kang; Seung Joon Chung; Choong Ho Shin; Sei Won Yang
Journal:  J Bone Miner Metab       Date:  2013-01-31       Impact factor: 2.626

9.  Plasma concentrations of vitamin D metabolites in unsupplemented breast-fed infants.

Authors:  T Markestad
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

10.  Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.

Authors:  A A Portale; B E Booth; B P Halloran; R C Morris
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.